103 related articles for article (PubMed ID: 16219411)
1. Effect of pesticides on estrogen receptor transactivation in vitro: a comparison of stable transfected MVLN and transient transfected MCF-7 cells.
Bonefeld-Jorgensen EC; Grünfeld HT; Gjermandsen IM
Mol Cell Endocrinol; 2005 Dec; 244(1-2):20-30. PubMed ID: 16219411
[TBL] [Abstract][Full Text] [Related]
2. Effect of in vitro estrogenic pesticides on human oestrogen receptor alpha and beta mRNA levels.
Grünfeld HT; Bonefeld-Jorgensen EC
Toxicol Lett; 2004 Aug; 151(3):467-80. PubMed ID: 15261991
[TBL] [Abstract][Full Text] [Related]
3. Effects of currently used pesticides in assays for estrogenicity, androgenicity, and aromatase activity in vitro.
Andersen HR; Vinggaard AM; Rasmussen TH; Gjermandsen IM; Bonefeld-Jørgensen EC
Toxicol Appl Pharmacol; 2002 Feb; 179(1):1-12. PubMed ID: 11884232
[TBL] [Abstract][Full Text] [Related]
4. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.
Ramamoorthy K; Wang F; Chen IC; Norris JD; McDonnell DP; Leonard LS; Gaido KW; Bocchinfuso WP; Korach KS; Safe S
Endocrinology; 1997 Apr; 138(4):1520-7. PubMed ID: 9075711
[TBL] [Abstract][Full Text] [Related]
5. Anti-estrogenic effect of unliganded progesterone receptor is estrogen-selective in breast cancer cells MCF-7.
Zheng ZY; Lin VC
Cancer Lett; 2008 Sep; 268(2):202-11. PubMed ID: 18477500
[TBL] [Abstract][Full Text] [Related]
6. Screening for estrogenicity and anti-estrogenicity: a critical evaluation of an MVLN cell-based transactivation assay.
Freyberger A; Schmuck G
Toxicol Lett; 2005 Jan; 155(1):1-13. PubMed ID: 15585354
[TBL] [Abstract][Full Text] [Related]
7. Recombinant cell bioassays for endocrine disruptors: development of a stably transfected human ovarian cell line for the detection of estrogenic and anti-estrogenic chemicals.
Rogers JM; Denison MS
In Vitr Mol Toxicol; 2000; 13(1):67-82. PubMed ID: 10900408
[TBL] [Abstract][Full Text] [Related]
8. Activation of bone morphogenetic protein-6 gene transcription in MCF-7 cells by estrogen.
Zhang M; Yan JD; Zhang L; Wang Q; Lü SJ; Zhang J; Zhu TH
Chin Med J (Engl); 2005 Oct; 118(19):1629-36. PubMed ID: 16232348
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structure, and estrogenic activity of 4-amino-3-(2-methylbenzyl)coumarins on human breast carcinoma cells.
Jacquot Y; Laïos I; Cleeren A; Nonclercq D; Bermont L; Refouvelet B; Boubekeur K; Xicluna A; Leclercq G; Laurent G
Bioorg Med Chem; 2007 Mar; 15(6):2269-82. PubMed ID: 17275315
[TBL] [Abstract][Full Text] [Related]
10. Currently used pesticides and their mixtures affect the function of sex hormone receptors and aromatase enzyme activity.
Kjeldsen LS; Ghisari M; Bonefeld-Jørgensen EC
Toxicol Appl Pharmacol; 2013 Oct; 272(2):453-64. PubMed ID: 23871939
[TBL] [Abstract][Full Text] [Related]
11. Effects of plasticizers and their mixtures on estrogen receptor and thyroid hormone functions.
Ghisari M; Bonefeld-Jorgensen EC
Toxicol Lett; 2009 Aug; 189(1):67-77. PubMed ID: 19463926
[TBL] [Abstract][Full Text] [Related]
12. Development of a stable dual cell-line GFP expression system to study estrogenic endocrine disruptors.
Xu H; Kraus WL; Shuler ML
Biotechnol Bioeng; 2008 Dec; 101(6):1276-87. PubMed ID: 18980187
[TBL] [Abstract][Full Text] [Related]
13. Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation.
Journe F; Laurent G; Chaboteaux C; Nonclercq D; Durbecq V; Larsimont D; Body JJ
Breast Cancer Res Treat; 2008 Jan; 107(1):49-61. PubMed ID: 17333335
[TBL] [Abstract][Full Text] [Related]
14. Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line.
Legler J; van den Brink CE; Brouwer A; Murk AJ; van der Saag PT; Vethaak AD; van der Burg B
Toxicol Sci; 1999 Mar; 48(1):55-66. PubMed ID: 10330684
[TBL] [Abstract][Full Text] [Related]
15. Estrogen-like effect and cytotoxicity of chemical compounds.
Katori Y; Ksu Y; Utsumi H
Water Sci Technol; 2002; 46(11-12):363-6. PubMed ID: 12523779
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the interaction of phytoestrogens and synthetic chemicals: an in vitro/in vivo comparison.
Charles GD; Gennings C; Tornesi B; Kan HL; Zacharewski TR; Bhaskar Gollapudi B; Carney EW
Toxicol Appl Pharmacol; 2007 Feb; 218(3):280-8. PubMed ID: 17222880
[TBL] [Abstract][Full Text] [Related]
17. In vitro bioactivity of 17alpha-estradiol.
Sievernich A; Wildt L; Lichtenberg-Fraté H
J Steroid Biochem Mol Biol; 2004 Dec; 92(5):455-63. PubMed ID: 15698550
[TBL] [Abstract][Full Text] [Related]
18. Enhanced formation of non-phenolic androgen metabolites with intrinsic oestrogen-like gene transactivation potency in human breast cancer cells: a distinctive metabolic pattern.
Pérez-Palacios G; Santillán R; García-Becerra R; Borja-Cacho E; Larrea F; Damián-Matsumura P; González L; Lemus AE
J Endocrinol; 2006 Sep; 190(3):805-18. PubMed ID: 17003281
[TBL] [Abstract][Full Text] [Related]
19. Extraction-dependent effects of American ginseng (Panax quinquefolium) on human breast cancer cell proliferation and estrogen receptor activation.
King ML; Adler SR; Murphy LL
Integr Cancer Ther; 2006 Sep; 5(3):236-43. PubMed ID: 16880429
[TBL] [Abstract][Full Text] [Related]
20. Effects of the antiestrogens tamoxifen and raloxifene on the estrogen receptor transactivation machinery.
Glaeser M; Niederacher D; Djahansouzi S; Hanstein B; Dittrich R; Beckmann MW; Fasching PA; Ackermann S
Anticancer Res; 2006; 26(1B):735-44. PubMed ID: 16739346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
